Frank J Mchugh, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211 Fax: 406-375-4590 |
Dr. Richard H Eggleston, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1224 W Main St, Hamilton, MT 59840 Phone: 406-363-0597 Fax: 406-375-4858 |
Clinton R Adkins, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211 Fax: 406-375-4590 |
Samuel P Urso, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211 Fax: 406-375-4590 |
Dr. William L Doyle, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211 Fax: 406-363-6536 |
Bristol Schmitz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211 |
Brian M Kelleher, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211 Fax: 406-375-4590 |
James G Hansen, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211 Fax: 406-363-6536 |
Benjamin J Watters, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211 Fax: 406-375-4590 |
Joshua M. Pacheco, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211 Fax: 406-375-4590 |
News Archive
For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.
Corning Incorporated (NYSE: GLW) and Geron Corporation (Nasdaq: GERN) today announced the successful development of novel synthetic surface matrices demonstrated to enhance and support the scalable manufacturing and growth of human embryonic stem cells (hESCs).
In 2009 the Patents Court of the High Court, Chancery Division, decided that Occlutech's range of Figulla ASD and PFO occluders do not infringe the U.K. part of European Patent 0 808 138. AGA Medical decided to appeal against this decision. The U.K. Court of Appeal (civil division) in London announced its decision confirming that said Figulla ASD and PFO occluders do not infringe said patent.
A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported.
› Verified 5 days ago